Eric Easom - 24 Oct 2022 Form 4 Insider Report for AN2 Therapeutics, Inc. (ANTX)

Role
Chief Executive Officer, Director
Signature
/s/ Lucy Day, Attorney-in-Fact for Eric Easom
Issuer symbol
ANTX
Transactions as of
24 Oct 2022
Transactions value $
-$147,358
Form type
4
Filing time
26 Oct 2022, 21:19:30 UTC
Previous filing
24 Oct 2022
Next filing
28 Oct 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANTX Common Stock Sale -$46.3K -2.87K -20.1% $16.17 11.4K 24 Oct 2022 Direct F1
transaction ANTX Common Stock Sale -$67K -4.27K -37.5% $15.69 7.12K 25 Oct 2022 Direct F1
transaction ANTX Common Stock Sale -$8.65K -534 -7.5% $16.20 6.59K 25 Oct 2022 Direct F1
transaction ANTX Common Stock Sale -$25.3K -1.68K -25.48% $15.10 4.91K 26 Oct 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.